Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275172
Max Phase: Preclinical
Molecular Formula: C20H35NO15
Molecular Weight: 529.49
Associated Items:
ID: ALA5275172
Max Phase: Preclinical
Molecular Formula: C20H35NO15
Molecular Weight: 529.49
Associated Items:
Canonical SMILES: CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](CO)O[C@H]1O
Standard InChI: InChI=1S/C20H35NO15/c1-5-10(25)12(27)14(29)19(32-5)36-17-9(21-6(2)24)18(31)33-8(4-23)16(17)35-20-15(30)13(28)11(26)7(3-22)34-20/h5,7-20,22-23,25-31H,3-4H2,1-2H3,(H,21,24)/t5-,7+,8+,9+,10+,11-,12+,13-,14-,15+,16+,17+,18+,19-,20-/m0/s1
Standard InChI Key: HBBOZFUQJDYASD-LPHOMBEVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 529.49 | Molecular Weight (Monoisotopic): 529.2007 | AlogP: -6.40 | #Rotatable Bonds: 7 |
Polar Surface Area: 257.32 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.43 | CX Basic pKa: | CX LogP: -5.72 | CX LogD: -5.72 |
Aromatic Rings: 0 | Heavy Atoms: 36 | QED Weighted: 0.15 | Np Likeness Score: 1.64 |
1. Cramer J.. (2021) Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN., 12 (12.0): [PMID:35024612] [10.1039/D1MD00238D] |
Source(1):